Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra 11:35:14 2024-04-24 am EDT After market 01:29:35 pm
27.32 EUR -1.23% Intraday chart for Fresenius SE & Co. KGaA 27.25 -0.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
FRESENIUS SE : Warburg Research reiterates its Buy rating ZD
FRESENIUS SE : Goldman Sachs sticks Neutral ZD
Verme family with other shareholders completed the acquisition of additional 70% stake in Clinica Ricardo Palma S.A. from Fresenius SE & Co. KGaA. CI
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading MT
FRESENIUS SE : Receives a Buy rating from Jefferies ZD
Barclays reads 'Overweight' for Fresenius SE - Target 35 Euro DP
FRESENIUS SE : Barclays reiterates its Buy rating ZD
FRESENIUS SE : Berenberg keeps its Buy rating ZD
Positive trend of FMC and Fresenius continues DP
FRESENIUS SE : Gets a Neutral rating from JP Morgan ZD
Lauterbach wants to press ahead with hospital reform despite differences DP
State report warns of risks in hospital reform DP
FRESENIUS SE : Deutsche Bank maintains a Buy rating ZD
Warnings against cutbacks in hospital reform DP
Federal and state governments to discuss hospital reform again DP
FRESENIUS SE : Gets a Buy rating from Deutsche Bank ZD
STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines RE
Fresenius at a two-month high - Tyenne launch and fantasy figures DP
Fresenius at two-month high - Tyenne launch a milestone DP
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading MT
Cannabis law and clinic atlas in the Bundesrat DP
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
Criticism of hospital reform: 'Redistribution from the bottom to the top' DP
Chart Fresenius SE & Co. KGaA
More charts
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.66 EUR
Average target price
36.22 EUR
Spread / Average Target
+30.94%
Consensus
  1. Stock Market
  2. Equities
  3. FRE Stock
  4. News Fresenius SE & Co. KGaA
  5. Germany's Fresenius Trims FY22 Outlook as Challenging Market Hits US-based Dialysis Business